吉林生殖健康男科医院(吉林睾丸突然疼痛是怎么回事) (今日更新中)

SAN FRANCISCO, June 9 (Xinhua) -- Hewlett-Packard Co. (HP) on Thursday announced that its tablet computer, HP TouchPad, will go on sale in the United States on July 1.Two versions of HP TouchPad, with the option of either 16 gigabytes or 32 gigabytes of internal storage, and both only with Wi-Fi connection, will be available in the United States for 499. 99 U.S. dollars and 599.99 dollars respectively, the company said in a statement.The product will hit stores in Britain, Ireland, France and Germany a few days later and in Canada in mid-July, with availability scheduled to follow later this year in Italy, Spain, Australia, China's Hong Kong, New Zealand and Singapore.Preorders in North America and Europe will begin on June 19, HP said.HP did not release the price details when it introduced TouchPad on Feb. 9. The black device, with a 9.7-inch touch screen, runs webOS operating system, a mobile platform developed by Palm, a smartphone maker acquired by HP last April for 1.8 billion dollars.

UNITED NATIONS, Sept. 19 (Xinhua) -- Mohammad Hossein Niknam, acting minister of health in international affairs of Iran, said here on Monday that his country is working to prevent and counteract the non-communicable diseases (NCDs), which have had significant effect on the population."NCDs have traditionally been more prevalent in affluent societies," he said. "However, they are increasingly becoming common in many developing countries, and in particular among the less affluent groups. The Eastern Mediterranean Region (EMRO) as others is suffering a heavy burden of NCD diseases and Iran is no exception: the total burden of disease for NCDs is 45 percent for males and 33 percent for females."Niknam's statements came as he addressed the UN General Assembly High-Level Meeting on Prevention and Control of Non- communicable Diseases."This timely high-level event provides us with an ideal platform to share views, information, ideas and experiences, to come up with remedial proposals and to forge effective collaborative partnerships in the implementation of realistic but effective health development programs in common areas of concern pertaining to the non-communicable diseases," Niknam said.He explained that Iran is implementing a series of programs in order to reduce the frequency and impacts of NCDs."As part of these programs I would like to mention prevention and control of common NCDs risk factors, imposition of taxes to curtail unhealthy habits such as tobacco consumption, execution of mass public information and educational campaigns, fostering food industry regulations, screening of blood pressure levels and high glucosemia," he said.Iran has created a Non-Communicable Diseases Risk Factor Surveillance System, according to Niknam. This system, in place since 2004, has conducted six large-scale surveys to gather information helpful to public health."Further, comprehensive cumulative national data has been compiled based on age, sex and location to facilitate effective monitoring and implementation of policies geared towards control and prevention of NCDs," Niknam said.Iran is conducting many other integrated NCD control and prevention programs, such as, to name a few, a Cardiovascular Diseases Control Program for rural areas; a National Cancer Control Program focusing on breast and colorectal cancers; and a Diabetes Control and Prevention Program that targets both rural and urban areas.Niknam ended his statement by noting that Iran has held regional consultations on the NCD issue."I would like to conclude my remarks by mentioning that as a sign of its commitment to promote regional and international cooperation, the Islamic Republic of Iran hosted on 25-26 October 2010 in Tehran the first regional meeting of a series of the regional consultations held by WHO (World Health Organization) on the prevention and control of NCDs," he said. "In our understanding, only through closer and meaningful collaboration at all levels, especially in areas such as legislation, resource mobilization and information and knowledge sharing, we may success in our endeavor to prevent and combat NCDs."

HONG KONG, July 19 (Xinhua) -- A gene controlled by male hormone was critical for the growth of liver tumor, leading to a higher incidence of the disease in men than in women, according to the Chinese University of Hong Kong which made the results public on Tuesday.There is a significant gender bias in liver cancer incidence. In Hong Kong, men are three times more likely to develop liver cancer than women. Such phenomenon prompted researchers from the university to carry out a genomic location analysis in liver cancer cells starting from 2008.The researchers discovered, out of 17,000 human genes, that a gene called Cell Cycle-Related Kinase (CCRK) was directly controlled by androgen receptor. They further found that CCRK was critical for the induction of signaling pathway leading to abnormal liver cell growth and tumor formation.The results also reveal that 70 percent of patients with liver cancer were found to produce high levels of CCRK. More importantly, these patients were more likely to have late-stage cancers and lived shorter than those with low CCRK level.Using mouse models, the researchers found that either lowering the level or blocking the signaling pathway of CCRK in liver cancer cells could significantly reduce the tumor growth rate.The study has validated that CCRK is an important gene that has potential to cause liver cancer and the gene can be tested as a new targeted therapy in future.Vice-Chancellor of the university Joseph Sung, who is also team leader of the research project, said the results explained why men have a higher risk of liver cancer than women and helped push ahead with the development of a novel treatment of the disease.The above study results were published online in July in Journal of Clinical Investigation.

WASHINGTON, Aug. 4 (Xinhua) -- U.S. scientists have found two gene mutations occurring in oligodendrogliomas, the second-most common form of brain cancer, according to a study to be published Friday in journal Science.For years scientists have been looking for the primary cancer genes involved in oligodendrogliomas evolvement. Scientists know the two chromosomes held the probable mutations, but the particular gene information remains unclear.Now scientists at Duke University Medical Center and Johns Hopkins University have discovered the most likely genetic mutations that researchers have been hunting for on chromosomes 1 and 19.The genes they identified, CIC or FUBP1, are tumor suppressor genes. The cancer-related pathways that involve these genes could become targets for future treatments, said Hai Yan, a Duke associate professor of pathology and co-corresponding author of the study.The researchers found CIC on chromosome 19 and FUBP1 on chromosome 1 based on an initial study of seven oligodendrogliomas. They found six mutations and two mutations, respectively, in the seven tumors. Further study of 27 more of these tumors showed that there were 12 and three mutations of CIC and FUBP1, respectively. The two genes were rarely mutated in other types of cancers, indicating that they are oligodendroglioma-specific genes.These genes were difficult to find until the technology improved, said Yan."The team used whole genome sequencing technology so that no genes would be excluded, and we found to our surprise that one gene, on chromosome 19, was mutated in six out of the seven initial tumor specimens we sequenced," Yan said. "A mutation frequency of 85 percent is very high."The finding of two additional new genes involved in oligodendrogliomas increases the chances for an effective combination drug therapy for the tumor, Yan said. He envisions a combination cocktail of drugs similar to the combination-drug treatments taken by HIV patients that would target different pathways involved in cancer, and assist both in reducing the chance of relapsing and increasing odds of success.

LOS ANGELES, July 6 (Xinhua) -- NASA scientists have got the first-ever, up-close details of a Saturn storm that is eight times the surface area of Earth, the Jet Propulsion Laboratory ( JPL) announced on Wednesday.The images were captured by NASA's Cassini spacecraf, according to JPL in Pasadena, Los Angeles.On Dec. 5, 2010, Cassini first detected the storm that has been raging ever since. It appears approximately 35 degrees north latitude of Saturn.The storm is the biggest observed by spacecraft orbiting or flying by Saturn. NASA's Hubble Space Telescope captured images in 1990 of an equally large storm.Pictures from Cassini's imaging cameras show the storm wrapping around the entire planet covering approximately two billion square miles (4 billion square kilometers).The storm is about 500 times larger than the biggest storm previously seen by Cassini during several months from 2009 to 2010. At its most intense, the storm generated more than 10 lightning flashes per second.Cassini has detected 10 lightning storms on Saturn since the spacecraft entered the planet's orbit.Those storms rolled through an area in the southern hemisphere dubbed "Storm Alley." "Cassini shows us that Saturn is bipolar," said Andrew Ingersoll, a Cassini imaging team member at the California Institute of Technology in Pasadena, California. "Saturn is not like Earth and Jupiter, where storms are fairly frequent. Weather on Saturn appears to hum along placidly for years and then erupt violently. I'm excited we saw weather so spectacular on our watch."The new details about this storm complement atmospheric disturbances described recently by scientists using Cassini's composite infrared spectrometer and the European Southern Observatory's Very Large Telescope. The Cassini-Huygens mission is a cooperative project of NASA, the European Space Agency and the Italian Space Agency. NASA's JPL manages the mission for the agency's Science Mission Directorate in Washington.

来源：资阳报